Cotización Delcath Systems - DCTH

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

11.94

Postura de Compra

11.58

Postura de Venta

13.59

Volume Operado de la Acción

442,779

11.82 Rango del Día 12.3655

3.12 Rango de 52 semanas 13.3011

Capitalización de Mercado [m]

381.767M

Precio Anterior

12.22

Precio de Apertura

12.33

Hora

12.53

Última hora de negociación

Volumen financiero

US$ 5,311,920

Precio Promedio Ponderado

11.9968

Volumen promedio (3 m)

370,764

Acciones en circulación

31,973,784

Rendimiento del Dividendo

Ratio Precio/Utilidad

-8.01

Beneficio por acción (BPA)

-1.49

turnover

2.07M

Beneficio neto

-47.68M

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Mostrar más

Sector

Surgical,med Instr,apparatus

Industria

Surgical,med Instr,apparatus

Sitio web

www.delcath.com

Sede

Wilmington, Delaware, USA

Fundado

Delcath Systems Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DCTH. The last closing price for Delcath Systems was US$12.22. Over the last year, Delcath Systems shares have traded in a share price range of US$ 3.12 to US$ 13.3011.

Delcath Systems currently has 31,973,784 shares in issue. The market capitalisation of Delcath Systems is US$390.72 million. Delcath Systems has a price to earnings ratio (PE ratio) of -8.01.

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.295	2.53327608416	11.645	13.3011	11.475	360403	12.08875438	CS
4	2.195	22.5243714726	9.745	13.3011	9.33	368141	11.27030935	CS
12	3.2	36.6132723112	8.74	13.3011	8.08	370764	10.42794047	CS
26	4.45	59.4125500668	7.49	13.3011	7.1701	322532	9.67145318	CS
52	8.75	274.294670846	3.19	13.3011	3.12	289374	7.6899365	CS
156	3.91	48.6924034869	8.03	13.3011	2.25	328244	5.91566802	CS
260	11.8401	11851.951952	0.0999	25.18	0.0999	247773	6.96373006	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.07M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.23M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	92.44M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.38M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.51M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	US$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	222.55M